Edition:
United Kingdom

Arqule announces $15.7 mln private placement of common stock


Monday, 16 Oct 2017 

Oct 16 (Reuters) - Arqule Inc :Arqule announces $15.7 million private placement of common stock.Arqule Inc - ‍intends to use net proceeds from offering to advance clinical trials related to its proprietary pipeline​.Arqule Inc - expects in first part of 2019 to obtain arq 531 PK/PD data from phase 1a trial in patients with refractory b-cell malignancies.Arqule inc - ‍company currently anticipates cash and marketable securities to provide funding into 2019​.Arqule Inc - ‍expects to end 2017 with between $38 and $40 million in cash and marketable securities​.Arqule Inc - expects in first part of 2019 to initiate phase 1b proof of concept trial​ for arq 531.Arqule-Expects in first part of 2019 to present authorities with proof of concept data to initiate registrational trial in proteus syndrome​ for ARQ 092. 

Company Quote

8.93
 --
19 Aug 2019